翰思艾泰生物医药科技（武汉）股份有限公司（股票名称：翰思艾泰-B，股票代码：03378）于2026年6月26日发布翌日披露报表，公告当日通过香港联交所场内回购4.4万股H股。
本次回购股份数量占回购前公司已发行股本（不包括库存股）约0.033%。每股回购价格介乎24.96港元至28港元，总金额约113.51万港元。回购完成后，公司已发行股本总数为136,218,830股，其中134,630,030股为已发行股份，1,588,800股为库存股。
公司表示，回购授权于2026年6月24日获股东大会批准，可回购总数为13,469,683股。截至公告时，公司已依据授权累计回购66,800股，占授权通过日公司已发行股本约0.0496%。
公告同时确认，上述回购行为已遵守香港联合交易所有限公司证券上市规则及相关法律法规。
本次公告由董事长兼执行董事张发明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.